Compare FT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FT | ORMP |
|---|---|---|
| Founded | 1988 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.8M | 170.3M |
| IPO Year | N/A | 2010 |
| Metric | FT | ORMP |
|---|---|---|
| Price | $7.84 | $4.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.3K | ★ 154.5K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 7.85% | 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.63 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $7.79 | $1.98 |
| 52 Week High | $8.35 | $5.19 |
| Indicator | FT | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 36.60 | 50.65 |
| Support Level | $7.84 | $3.91 |
| Resistance Level | $8.08 | $4.22 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 13.33 | 46.37 |
Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.